Buy Hold Sell, by Livewire Markets

Buy Hold Sell: 5 value stocks set to prosper in a bear market

Value stocks have been long forgotten. But during this bear market, will they be remembered by investors and come back into vogue?

In this episode of Buy Hold Sell, Simon Shields from Monash Investors and Anthony Aboud from Perpetual Investments join Matthew Kidman to talk all about the potential resurgence of value stocks and their future prospects. They are: 1) Telstra, an old Australian favourite with potential for a 4-5% yield; 2) JB HI-FI, a retailer who is winning throughout the covid crisis; 3) AP Eagers, the biggest car dealership in Australia, whose stock price has more than halved in the last 12 months. Simon and Anthony also reveal two of their own stocks that are both compelling and of good value.

Notes: This episode was filmed on 6 May 2020. You can access the video and edited transcript for this Buy Hold Sell episode here.

 

Buy Hold Sell: 5 ex-20 stocks ready to roar

A handful of stocks outside the ASX 20 have proved especially popular during the COVID-19 induced stock market rout and (contentious) recovery, according to data provided by Sharesight.

In this episode, Ben Rundle of NAOS Asset Management and Michelle Lopez from Aberdeen Standard Investments debate whether the stocks investors have been stockpiling are truly essential items for your portfolio. They are: 1) Altium - which recently withdrew its earnings guidance; 2) EML Payments - down ~60% from its peak as lockdowns smash discretionary and business spending; 3) Sonic Healthcare - a key player in coronavirus testing but off 25% from its all-time high. Michelle and Ben also present their two favourite ex-20 growth stocks being materially underappreciated by the market.

You can access the video and edited transcript for this Buy Hold Sell episode here.

Notes: Altium, EML and Sonic Healthcare were among Sharesight customers' most-traded stocks from the period 1 April to 15 April 2020. This video was filmed on 22 April 2020.

Opportunity or emergency? A guide to assessing capital raisings

In 2019, nobody would have expected the likes of Cochlear to hold a capital raising anytime soon, but amid a severe and sudden collapse in earnings, companies have asked investors for more than $9 billion of equity capital to survive and in some cases, thrive. In this extended interview, Michelle Lopez of Aberdeen Standard Investments and Ben Rundle from NAOS Asset Management discuss:

• How to assess a good deal
• The deal breakers of a capital raising
• The structure of a capital raising
• How to manage capital raisings in your portfolio
• Current capital raising opportunities

On our website, we've published a table to show you equity raisings announced due to COVID-19 and the ones Michelle and Ben are participating in. You can also access the video and full transcript on that page.

Note: This video was recorded on 22 April 2020.

Buy Hold Sell: 5 pandemic-resistant growth stocks

It may be a gloomy backdrop for the economy as many companies cancel their earnings guidance due to the coronavirus-driven downturn. But even in this environment, there are a handful of stocks whose earnings refuse to go into lockdown.

In this episode, Michelle Lopez from Aberdeen Standard Investments and Ben Rundle of NAOS Asset Management join Vishal Teckchandani discuss 5 businesses that can help immunise your portfolio from a cyclical slump: 1) a company benefiting from booming data consumption; 2) a tech stock bucking the guidance-scrapping trend; 3) a business providing essential services to households; 4) a WAAAX stock that keeps on chugging and 5) a small-cap riding higher usage of voice, video and messaging apps.

Note: This video was recorded on 22 April 2020. Access the full transcript (including stock codes) and podcast here.

Buy Hold Sell: 6 companies that are set to come out swinging

In the midst of a crisis, it’s time to start thinking long term. In five years time, what companies will still be growing? Which companies have what it takes to prosper through this crisis?

In this special global equities edition of Buy Hold Sell Matthew Kidman is joined by Charlie Aitken from Aitken Investment Management and Nick Griffin from Munro Partners to debate the prospects of Nike, popular streaming service Netflix, Chinese e-commerce giant Alibaba and electric car juggernaut Tesla, along with 2 other, interesting companies that are set to soar in the long term.

Notes: This episode was filmed on 7 April 2020. You can access the video, podcast or edited transcript (containing the stock codes) for this Buy Hold Sell episode here.

Portfolio strategy: 4 ways to win in a changing world

The lyrics “turn and face the strange” from David Bowie’s 1971 hit song “Changes” could not be a more fitting way to describe the challenges investors are facing today. COVID-19 has raised doubts about themes that many considered structural and sound such as the desire (or need) to travel, the use of office space and the pain befalling banks and insurers as a result of low interest rates and a global economy veering into recession.

In this extended interview, Charlie Aitken of Aitken Investment Management and Nick Griffin of Munro Partners discuss the big changes occurring in consumer behaviour and markets as well as “dead-end streets” – as Bowie put it - to avoid. They also share 4 stock ideas; companies with “fortress balance sheets” set to emerge even stronger on the other side.

Notes: This episode was filmed on 7 April 2020. You can access the video, podcast or edited transcript (which includes the stock codes) for this episode here.

Buy Hold Sell: 6 international stocks for the coronavirus economy

Who knew that in 1982 when Fat Larry’s Band sang “Zoom” that it would become synonymous with the name of the A$57 billion software company that’s enabled the work-from-home era? Despite mass-lockdowns, Zoom and a bunch of other companies are seeing their share prices ‘flyin’ high in a neon sky’ amid the coronavirus economy.

 

In this global equities special, Nick Griffin of Munro Partners and Charlie Aitken of Aitken Investment Management chat to Matthew Kidman about the prospects for Zoom (NAS:ZM); media streaming app Spotify (NYS:SPOT); e-commerce and cloud titan Amazon (NAS:AMZN) and COVID-19 vaccine frontrunner Johnson & Johnson (NYS:JNJ). They also nominate 2 other high quality, reasonably priced stocks which may see ‘no turnin’ back’ down the track.

Notes: This episode was filmed on 7 April 2020. You can access the video, podcast or edited transcript (containing the ticker codes) for this Buy Hold Sell episode below here.

 

Buy Hold Sell: 5 beaten-down stocks, and 1 ‘high octane’ idea

One of the themes that emerged from Saturday's extended interview with Ben McGarry of Totus Capital and Steve Johnson from Forager Funds was for investors to check their portfolio and evaluate the balance sheets of their holdings.

In this episode, we get Ben and Steve to put some widely-held stocks under a stress test and gauge whether they have what it takes to ride out the rapidly deteriorating economic environment. The names include Tabcorp, Carsales.com, Afterpay, G8 Education and Super Retail Group.

Steve also offers Livewire subscribers a 'high octane' stock idea that he reckons is being "dramatically mispriced". This company has government and corporate contracts, and could see a severalfold increase if it retains them and conditions bounce back.

Notes: You can access the video and edited transcript for this Buy Hold Sell episode below here: https://www.livewiremarkets.com/wires/buy-hold-sell-5-beaten-down-stocks-and-1-high-octane-idea

This episode was filmed on 25 March 2020.

Have share price falls overshot economic reality?

The Australian equity market at one stage fell nearly 35% from its all-time high in just over a month amid the COVID-19 crisis.

The challenge for investors is working out - against huge swathes of data and human emotion – whether shares are priced correctly against wartime stimulus measures, an impending recession and a pandemic with vague signs of subsiding.

In this interview, Ben McGarry of Totus Capital and Steve Johnson of Forager Funds join James Marlay to debate whether the market has priced in the economic situation efficiently. They also discuss whether investors are getting sucked in by “bear market bounces”, important things to check within your portfolio and the greatest opportunities in this environment.

Notes: You can access the video, podcast or edited transcript for this Buy Hold Sell episode here.

This episode was filmed on 25 March 2020.

Buy Hold Sell: 5 cash earners for a crisis

With Covid-19 effectively cancelling the economy, nothing is more important from an investment perspective than a company's ability to generate cash flow to get through this unprecedented period.

As such, we've brought together Steve Johnson of Forager Funds and Ben McGarry from Totus Capital to discuss stocks poised to be cash earners or cash burners in a cycle that'll likely be marked by Australia's first recession in nearly three decades.

The companies are 1) National Australia Bank, whose share price recently fell to 1996 lows, 2) Cochlear, hit by a triple whammy of Covid-19, an adverse court ruling and the need to raise capital and 3) Xero, which is facing a fall in subscriptions as businesses close their doors. Steve and Ben also share 2 small-cap ideas they reckon will thrive on the other side of the crisis.

Notes: You can access the video or edited transcript for this Buy Hold Sell episode here.

This episode was recorded on 25 March 2020.